Global Amyloidosis Therapeutics Market Research Report 2025(Status and Outlook)

March 2025 | 183 pages | ID: GB5173FEB8E8EN
Bosson Research

Abstracts

Report Overview

Amyloidosis therapeutics refer to the various treatments and medications aimed at managing and treating amyloidosis, a rare disease characterized by the abnormal accumulation of amyloid proteins in tissues and organs. These therapeutics include drugs that target the underlying causes of amyloidosis, such as reducing the production of amyloid proteins or enhancing their clearance from the body. Additionally, supportive therapies may be included to manage symptoms and improve patients' quality of life. The market for amyloidosis therapeutics is driven by the increasing prevalence of amyloidosis worldwide, advancements in medical research leading to the development of novel treatment options, and growing awareness among healthcare professionals and patients about the disease. As a result, pharmaceutical companies are investing in research and development activities to introduce innovative therapies for amyloidosis, thereby expanding the market and improving patient outcomes.

The market for amyloidosis therapeutics is witnessing a positive trend with a focus on personalized medicine and targeted therapies. This trend is driven by the growing understanding of the heterogeneity of amyloidosis subtypes and the need for tailored treatment approaches based on individual patient characteristics. Moreover, the market is also influenced by the rising healthcare expenditure globally, especially in developed countries, which allows for better access to advanced therapeutics for amyloidosis. In addition, collaborations between pharmaceutical companies, research institutions, and patient advocacy groups are fostering the development of new treatment options and accelerating the regulatory approval process. Overall, the market for amyloidosis therapeutics is poised for significant growth in the coming years, with a strong emphasis on innovation, patient-centric care, and improved treatment outcomes.

This report provides a deep insight into the global Amyloidosis Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Amyloidosis Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Amyloidosis Therapeutics market in any manner.

Global Amyloidosis Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Pfizer Inc.

ProteoTech

Inc.

Alnylam Pharmaceuticals

Inc.

Arcturus Therapeutics

Inc

Bellus Health Inc.

Bsim2

Celgene Corporation

Millennium Pharmaceuticals

Inc.

Onyx Pharmaceuticals

Inc.

GlaxoSmithKline Plc

Isis Pharmaceuticals

Inc.

Prothena Corporation Plc

SOM Innovation Biotech SL

Market Segmentation (by Type)

AG-10

ALN-ANG

ALN-TTRsc02

CAEL-101

Canakinumab

Others

Market Segmentation (by Application)

AL Amyloidosis

AA Amyloidoses

ATTR Amyloidoses

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Amyloidosis Therapeutics Market
• Overview of the regional outlook of the Amyloidosis Therapeutics Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Amyloidosis Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Amyloidosis Therapeutics
1.2 Key Market Segments
1.2.1 Amyloidosis Therapeutics Segment by Type
1.2.2 Amyloidosis Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Amyloidosis Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Amyloidosis Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Amyloidosis Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Amyloidosis Therapeutics Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Amyloidosis Therapeutics Product Life Cycle
3.3 Global Amyloidosis Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Amyloidosis Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Amyloidosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Amyloidosis Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Amyloidosis Therapeutics Manufacturing Sites, Area Served, Product Type
3.8 Amyloidosis Therapeutics Market Competitive Situation and Trends
3.8.1 Amyloidosis Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Amyloidosis Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Amyloidosis Therapeutics Industry Chain Analysis
4.1 Amyloidosis Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Amyloidosis Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Amyloidosis Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Amyloidosis Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 Amyloidosis Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Amyloidosis Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Amyloidosis Therapeutics Market Size Market Share by Type (2020-2025)
6.4 Global Amyloidosis Therapeutics Price by Type (2020-2025)
7 Amyloidosis Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Amyloidosis Therapeutics Market Sales by Application (2020-2025)
7.3 Global Amyloidosis Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Amyloidosis Therapeutics Sales Growth Rate by Application (2020-2025)
8 Amyloidosis Therapeutics Market Sales by Region
8.1 Global Amyloidosis Therapeutics Sales by Region
8.1.1 Global Amyloidosis Therapeutics Sales by Region
8.1.2 Global Amyloidosis Therapeutics Sales Market Share by Region
8.2 Global Amyloidosis Therapeutics Market Size by Region
8.2.1 Global Amyloidosis Therapeutics Market Size by Region
8.2.2 Global Amyloidosis Therapeutics Market Size Market Share by Region
8.3 North America
8.3.1 North America Amyloidosis Therapeutics Sales by Country
8.3.2 North America Amyloidosis Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Amyloidosis Therapeutics Sales by Country
8.4.2 Europe Amyloidosis Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Amyloidosis Therapeutics Sales by Region
8.5.2 Asia Pacific Amyloidosis Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Amyloidosis Therapeutics Sales by Country
8.6.2 South America Amyloidosis Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Amyloidosis Therapeutics Sales by Region
8.7.2 Middle East and Africa Amyloidosis Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Amyloidosis Therapeutics Market Production by Region
9.1 Global Production of Amyloidosis Therapeutics by Region(2020-2025)
9.2 Global Amyloidosis Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Amyloidosis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Amyloidosis Therapeutics Production
9.4.1 North America Amyloidosis Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Amyloidosis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Amyloidosis Therapeutics Production
9.5.1 Europe Amyloidosis Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Amyloidosis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Amyloidosis Therapeutics Production (2020-2025)
9.6.1 Japan Amyloidosis Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Amyloidosis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Amyloidosis Therapeutics Production (2020-2025)
9.7.1 China Amyloidosis Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Amyloidosis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Pfizer Inc.
10.1.1 Pfizer Inc. Basic Information
10.1.2 Pfizer Inc. Amyloidosis Therapeutics Product Overview
10.1.3 Pfizer Inc. Amyloidosis Therapeutics Product Market Performance
10.1.4 Pfizer Inc. Business Overview
10.1.5 Pfizer Inc. SWOT Analysis
10.1.6 Pfizer Inc. Recent Developments
10.2 ProteoTech
10.2.1 ProteoTech Basic Information
10.2.2 ProteoTech Amyloidosis Therapeutics Product Overview
10.2.3 ProteoTech Amyloidosis Therapeutics Product Market Performance
10.2.4 ProteoTech Business Overview
10.2.5 ProteoTech SWOT Analysis
10.2.6 ProteoTech Recent Developments
10.3 Inc.
10.3.1 Inc. Basic Information
10.3.2 Inc. Amyloidosis Therapeutics Product Overview
10.3.3 Inc. Amyloidosis Therapeutics Product Market Performance
10.3.4 Inc. Business Overview
10.3.5 Inc. SWOT Analysis
10.3.6 Inc. Recent Developments
10.4 Alnylam Pharmaceuticals
10.4.1 Alnylam Pharmaceuticals Basic Information
10.4.2 Alnylam Pharmaceuticals Amyloidosis Therapeutics Product Overview
10.4.3 Alnylam Pharmaceuticals Amyloidosis Therapeutics Product Market Performance
10.4.4 Alnylam Pharmaceuticals Business Overview
10.4.5 Alnylam Pharmaceuticals Recent Developments
10.5 Inc.
10.5.1 Inc. Basic Information
10.5.2 Inc. Amyloidosis Therapeutics Product Overview
10.5.3 Inc. Amyloidosis Therapeutics Product Market Performance
10.5.4 Inc. Business Overview
10.5.5 Inc. Recent Developments
10.6 Arcturus Therapeutics
10.6.1 Arcturus Therapeutics Basic Information
10.6.2 Arcturus Therapeutics Amyloidosis Therapeutics Product Overview
10.6.3 Arcturus Therapeutics Amyloidosis Therapeutics Product Market Performance
10.6.4 Arcturus Therapeutics Business Overview
10.6.5 Arcturus Therapeutics Recent Developments
10.7 Inc
10.7.1 Inc Basic Information
10.7.2 Inc Amyloidosis Therapeutics Product Overview
10.7.3 Inc Amyloidosis Therapeutics Product Market Performance
10.7.4 Inc Business Overview
10.7.5 Inc Recent Developments
10.8 Bellus Health Inc.
10.8.1 Bellus Health Inc. Basic Information
10.8.2 Bellus Health Inc. Amyloidosis Therapeutics Product Overview
10.8.3 Bellus Health Inc. Amyloidosis Therapeutics Product Market Performance
10.8.4 Bellus Health Inc. Business Overview
10.8.5 Bellus Health Inc. Recent Developments
10.9 Bsim2
10.9.1 Bsim2 Basic Information
10.9.2 Bsim2 Amyloidosis Therapeutics Product Overview
10.9.3 Bsim2 Amyloidosis Therapeutics Product Market Performance
10.9.4 Bsim2 Business Overview
10.9.5 Bsim2 Recent Developments
10.10 Celgene Corporation
10.10.1 Celgene Corporation Basic Information
10.10.2 Celgene Corporation Amyloidosis Therapeutics Product Overview
10.10.3 Celgene Corporation Amyloidosis Therapeutics Product Market Performance
10.10.4 Celgene Corporation Business Overview
10.10.5 Celgene Corporation Recent Developments
10.11 Millennium Pharmaceuticals
10.11.1 Millennium Pharmaceuticals Basic Information
10.11.2 Millennium Pharmaceuticals Amyloidosis Therapeutics Product Overview
10.11.3 Millennium Pharmaceuticals Amyloidosis Therapeutics Product Market Performance
10.11.4 Millennium Pharmaceuticals Business Overview
10.11.5 Millennium Pharmaceuticals Recent Developments
10.12 Inc.
10.12.1 Inc. Basic Information
10.12.2 Inc. Amyloidosis Therapeutics Product Overview
10.12.3 Inc. Amyloidosis Therapeutics Product Market Performance
10.12.4 Inc. Business Overview
10.12.5 Inc. Recent Developments
10.13 Onyx Pharmaceuticals
10.13.1 Onyx Pharmaceuticals Basic Information
10.13.2 Onyx Pharmaceuticals Amyloidosis Therapeutics Product Overview
10.13.3 Onyx Pharmaceuticals Amyloidosis Therapeutics Product Market Performance
10.13.4 Onyx Pharmaceuticals Business Overview
10.13.5 Onyx Pharmaceuticals Recent Developments
10.14 Inc.
10.14.1 Inc. Basic Information
10.14.2 Inc. Amyloidosis Therapeutics Product Overview
10.14.3 Inc. Amyloidosis Therapeutics Product Market Performance
10.14.4 Inc. Business Overview
10.14.5 Inc. Recent Developments
10.15 GlaxoSmithKline Plc
10.15.1 GlaxoSmithKline Plc Basic Information
10.15.2 GlaxoSmithKline Plc Amyloidosis Therapeutics Product Overview
10.15.3 GlaxoSmithKline Plc Amyloidosis Therapeutics Product Market Performance
10.15.4 GlaxoSmithKline Plc Business Overview
10.15.5 GlaxoSmithKline Plc Recent Developments
10.16 Isis Pharmaceuticals
10.16.1 Isis Pharmaceuticals Basic Information
10.16.2 Isis Pharmaceuticals Amyloidosis Therapeutics Product Overview
10.16.3 Isis Pharmaceuticals Amyloidosis Therapeutics Product Market Performance
10.16.4 Isis Pharmaceuticals Business Overview
10.16.5 Isis Pharmaceuticals Recent Developments
10.17 Inc.
10.17.1 Inc. Basic Information
10.17.2 Inc. Amyloidosis Therapeutics Product Overview
10.17.3 Inc. Amyloidosis Therapeutics Product Market Performance
10.17.4 Inc. Business Overview
10.17.5 Inc. Recent Developments
10.18 Prothena Corporation Plc
10.18.1 Prothena Corporation Plc Basic Information
10.18.2 Prothena Corporation Plc Amyloidosis Therapeutics Product Overview
10.18.3 Prothena Corporation Plc Amyloidosis Therapeutics Product Market Performance
10.18.4 Prothena Corporation Plc Business Overview
10.18.5 Prothena Corporation Plc Recent Developments
10.19 SOM Innovation Biotech SL
10.19.1 SOM Innovation Biotech SL Basic Information
10.19.2 SOM Innovation Biotech SL Amyloidosis Therapeutics Product Overview
10.19.3 SOM Innovation Biotech SL Amyloidosis Therapeutics Product Market Performance
10.19.4 SOM Innovation Biotech SL Business Overview
10.19.5 SOM Innovation Biotech SL Recent Developments
11 Amyloidosis Therapeutics Market Forecast by Region
11.1 Global Amyloidosis Therapeutics Market Size Forecast
11.2 Global Amyloidosis Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Amyloidosis Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Amyloidosis Therapeutics Market Size Forecast by Region
11.2.4 South America Amyloidosis Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Amyloidosis Therapeutics by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Amyloidosis Therapeutics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Amyloidosis Therapeutics by Type (2026-2033)
12.1.2 Global Amyloidosis Therapeutics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Amyloidosis Therapeutics by Type (2026-2033)
12.2 Global Amyloidosis Therapeutics Market Forecast by Application (2026-2033)
12.2.1 Global Amyloidosis Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Amyloidosis Therapeutics Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Amyloidosis Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Amyloidosis Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Amyloidosis Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Amyloidosis Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Amyloidosis Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyloidosis Therapeutics as of 2024)
Table 10. Global Market Amyloidosis Therapeutics Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Amyloidosis Therapeutics Manufacturing Sites and Area Served
Table 12. Manufacturers Amyloidosis Therapeutics Product Type
Table 13. Global Amyloidosis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Amyloidosis Therapeutics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Amyloidosis Therapeutics Sales by Type (K MT)
Table 25. Global Amyloidosis Therapeutics Market Size by Type (M USD)
Table 26. Global Amyloidosis Therapeutics Sales (K MT) by Type (2020-2025)
Table 27. Global Amyloidosis Therapeutics Sales Market Share by Type (2020-2025)
Table 28. Global Amyloidosis Therapeutics Market Size (M USD) by Type (2020-2025)
Table 29. Global Amyloidosis Therapeutics Market Size Share by Type (2020-2025)
Table 30. Global Amyloidosis Therapeutics Price (USD/MT) by Type (2020-2025)
Table 31. Global Amyloidosis Therapeutics Sales (K MT) by Application
Table 32. Global Amyloidosis Therapeutics Market Size by Application
Table 33. Global Amyloidosis Therapeutics Sales by Application (2020-2025) & (K MT)
Table 34. Global Amyloidosis Therapeutics Sales Market Share by Application (2020-2025)
Table 35. Global Amyloidosis Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 36. Global Amyloidosis Therapeutics Market Share by Application (2020-2025)
Table 37. Global Amyloidosis Therapeutics Sales Growth Rate by Application (2020-2025)
Table 38. Global Amyloidosis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 39. Global Amyloidosis Therapeutics Sales Market Share by Region (2020-2025)
Table 40. Global Amyloidosis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 41. Global Amyloidosis Therapeutics Market Size Market Share by Region (2020-2025)
Table 42. North America Amyloidosis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 43. North America Amyloidosis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Amyloidosis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 45. Europe Amyloidosis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Amyloidosis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Amyloidosis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 48. South America Amyloidosis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 49. South America Amyloidosis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Amyloidosis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Amyloidosis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 52. Global Amyloidosis Therapeutics Production (K MT) by Region(2020-2025)
Table 53. Global Amyloidosis Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Amyloidosis Therapeutics Revenue Market Share by Region (2020-2025)
Table 55. Global Amyloidosis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Amyloidosis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Amyloidosis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Amyloidosis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Amyloidosis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Pfizer Inc. Basic Information
Table 61. Pfizer Inc. Amyloidosis Therapeutics Product Overview
Table 62. Pfizer Inc. Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Pfizer Inc. Business Overview
Table 64. Pfizer Inc. SWOT Analysis
Table 65. Pfizer Inc. Recent Developments
Table 66. ProteoTech Basic Information
Table 67. ProteoTech Amyloidosis Therapeutics Product Overview
Table 68. ProteoTech Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. ProteoTech Business Overview
Table 70. ProteoTech SWOT Analysis
Table 71. ProteoTech Recent Developments
Table 72. Inc. Basic Information
Table 73. Inc. Amyloidosis Therapeutics Product Overview
Table 74. Inc. Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Inc. Business Overview
Table 76. Inc. SWOT Analysis
Table 77. Inc. Recent Developments
Table 78. Alnylam Pharmaceuticals Basic Information
Table 79. Alnylam Pharmaceuticals Amyloidosis Therapeutics Product Overview
Table 80. Alnylam Pharmaceuticals Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Alnylam Pharmaceuticals Business Overview
Table 82. Alnylam Pharmaceuticals Recent Developments
Table 83. Inc. Basic Information
Table 84. Inc. Amyloidosis Therapeutics Product Overview
Table 85. Inc. Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Inc. Business Overview
Table 87. Inc. Recent Developments
Table 88. Arcturus Therapeutics Basic Information
Table 89. Arcturus Therapeutics Amyloidosis Therapeutics Product Overview
Table 90. Arcturus Therapeutics Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Arcturus Therapeutics Business Overview
Table 92. Arcturus Therapeutics Recent Developments
Table 93. Inc Basic Information
Table 94. Inc Amyloidosis Therapeutics Product Overview
Table 95. Inc Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Inc Business Overview
Table 97. Inc Recent Developments
Table 98. Bellus Health Inc. Basic Information
Table 99. Bellus Health Inc. Amyloidosis Therapeutics Product Overview
Table 100. Bellus Health Inc. Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Bellus Health Inc. Business Overview
Table 102. Bellus Health Inc. Recent Developments
Table 103. Bsim2 Basic Information
Table 104. Bsim2 Amyloidosis Therapeutics Product Overview
Table 105. Bsim2 Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Bsim2 Business Overview
Table 107. Bsim2 Recent Developments
Table 108. Celgene Corporation Basic Information
Table 109. Celgene Corporation Amyloidosis Therapeutics Product Overview
Table 110. Celgene Corporation Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Celgene Corporation Business Overview
Table 112. Celgene Corporation Recent Developments
Table 113. Millennium Pharmaceuticals Basic Information
Table 114. Millennium Pharmaceuticals Amyloidosis Therapeutics Product Overview
Table 115. Millennium Pharmaceuticals Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Millennium Pharmaceuticals Business Overview
Table 117. Millennium Pharmaceuticals Recent Developments
Table 118. Inc. Basic Information
Table 119. Inc. Amyloidosis Therapeutics Product Overview
Table 120. Inc. Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Inc. Business Overview
Table 122. Inc. Recent Developments
Table 123. Onyx Pharmaceuticals Basic Information
Table 124. Onyx Pharmaceuticals Amyloidosis Therapeutics Product Overview
Table 125. Onyx Pharmaceuticals Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Onyx Pharmaceuticals Business Overview
Table 127. Onyx Pharmaceuticals Recent Developments
Table 128. Inc. Basic Information
Table 129. Inc. Amyloidosis Therapeutics Product Overview
Table 130. Inc. Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 131. Inc. Business Overview
Table 132. Inc. Recent Developments
Table 133. GlaxoSmithKline Plc Basic Information
Table 134. GlaxoSmithKline Plc Amyloidosis Therapeutics Product Overview
Table 135. GlaxoSmithKline Plc Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 136. GlaxoSmithKline Plc Business Overview
Table 137. GlaxoSmithKline Plc Recent Developments
Table 138. Isis Pharmaceuticals Basic Information
Table 139. Isis Pharmaceuticals Amyloidosis Therapeutics Product Overview
Table 140. Isis Pharmaceuticals Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 141. Isis Pharmaceuticals Business Overview
Table 142. Isis Pharmaceuticals Recent Developments
Table 143. Inc. Basic Information
Table 144. Inc. Amyloidosis Therapeutics Product Overview
Table 145. Inc. Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 146. Inc. Business Overview
Table 147. Inc. Recent Developments
Table 148. Prothena Corporation Plc Basic Information
Table 149. Prothena Corporation Plc Amyloidosis Therapeutics Product Overview
Table 150. Prothena Corporation Plc Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 151. Prothena Corporation Plc Business Overview
Table 152. Prothena Corporation Plc Recent Developments
Table 153. SOM Innovation Biotech SL Basic Information
Table 154. SOM Innovation Biotech SL Amyloidosis Therapeutics Product Overview
Table 155. SOM Innovation Biotech SL Amyloidosis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 156. SOM Innovation Biotech SL Business Overview
Table 157. SOM Innovation Biotech SL Recent Developments
Table 158. Global Amyloidosis Therapeutics Sales Forecast by Region (2026-2033) & (K MT)
Table 159. Global Amyloidosis Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 160. North America Amyloidosis Therapeutics Sales Forecast by Country (2026-2033) & (K MT)
Table 161. North America Amyloidosis Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 162. Europe Amyloidosis Therapeutics Sales Forecast by Country (2026-2033) & (K MT)
Table 163. Europe Amyloidosis Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 164. Asia Pacific Amyloidosis Therapeutics Sales Forecast by Region (2026-2033) & (K MT)
Table 165. Asia Pacific Amyloidosis Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 166. South America Amyloidosis Therapeutics Sales Forecast by Country (2026-2033) & (K MT)
Table 167. South America Amyloidosis Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 168. Middle East and Africa Amyloidosis Therapeutics Sales Forecast by Country (2026-2033) & (Units)
Table 169. Middle East and Africa Amyloidosis Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 170. Global Amyloidosis Therapeutics Sales Forecast by Type (2026-2033) & (K MT)
Table 171. Global Amyloidosis Therapeutics Market Size Forecast by Type (2026-2033) & (M USD)
Table 172. Global Amyloidosis Therapeutics Price Forecast by Type (2026-2033) & (USD/MT)
Table 173. Global Amyloidosis Therapeutics Sales (K MT) Forecast by Application (2026-2033)
Table 174. Global Amyloidosis Therapeutics Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Amyloidosis Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Amyloidosis Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Amyloidosis Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Amyloidosis Therapeutics Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Amyloidosis Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Amyloidosis Therapeutics Product Life Cycle
Figure 13. Amyloidosis Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Amyloidosis Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Amyloidosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Amyloidosis Therapeutics Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Amyloidosis Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Amyloidosis Therapeutics
Figure 19. Global Amyloidosis Therapeutics Market PEST Analysis
Figure 20. Global Amyloidosis Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Amyloidosis Therapeutics Market Share by Type
Figure 27. Sales Market Share of Amyloidosis Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Amyloidosis Therapeutics by Type in 2024
Figure 29. Market Size Share of Amyloidosis Therapeutics by Type (2020-2025)
Figure 30. Market Size Share of Amyloidosis Therapeutics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Amyloidosis Therapeutics Market Share by Application
Figure 33. Global Amyloidosis Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Amyloidosis Therapeutics Sales Market Share by Application in 2024
Figure 35. Global Amyloidosis Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Amyloidosis Therapeutics Market Share by Application in 2024
Figure 37. Global Amyloidosis Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Amyloidosis Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Amyloidosis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 40. North America Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Amyloidosis Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Amyloidosis Therapeutics Market Size Market Share by Country in 2024
Figure 45. U.S. Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Amyloidosis Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Amyloidosis Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Amyloidosis Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Amyloidosis Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Amyloidosis Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Amyloidosis Therapeutics Market Size Market Share by Country in 2024
Figure 55. Germany Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Amyloidosis Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Amyloidosis Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Amyloidosis Therapeutics Market Size Market Share by Region in 2024
Figure 68. China Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Amyloidosis Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Amyloidosis Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Amyloidosis Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Amyloidosis Therapeutics Market Size Market Share by Country in 2024
Figure 82. Brazil Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Amyloidosis Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Amyloidosis Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Amyloidosis Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Amyloidosis Therapeutics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Amyloidosis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Amyloidosis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Amyloidosis Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Amyloidosis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Amyloidosis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Amyloidosis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Amyloidosis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Amyloidosis Therapeutics Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Amyloidosis Therapeutics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Amyloidosis Therapeutics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Amyloidosis Therapeutics Market Share Forecast by Type (2026-2033)
Figure 111. Global Amyloidosis Therapeutics Sales Forecast by Application (2026-2033)
Figure 112. Global Amyloidosis Therapeutics Market Share Forecast by Application (2026-2033)